Why merge with Mallinckrodt? In April 2014, Questcor and Dublin-based Mallinckrodt Pharmaceuticals announced a definitive merger agreement that gives every Questcor shareholder $30 in cash and .897 shares of Mallinckrodt ( MNK ). As per CEO Mark Trudeau's comments, the merger will "provide a strong and sustainable platform for future revenue and earnings growth."